Skip to main content

Tekmira Releases Preclinical Data on Lipid Delivery of mRNA

Premium

Tekmira Pharmaceuticals this week announced the release of preclinical data showing that its lipid nanoparticles can be used to deliver messenger RNA into the liver, tumors, and other tissues in vivo.

The data were presented at the International mRNA Health conference in Germany this week.

"Because [lipid nanoparticles] can enable a wide variety of nucleic acid payloads, including messenger RNA, we continue to see new product development and partnering opportunities based on our … delivery expertise," Tekmira President and CEO Mark Murray said in a statement.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.